Comparative Study: Long-Term Neurodevelopmental Outcomes in Neonates Treated with Lacosamide vs Other Antiseizure Medications for Neonatal Seizures

Study type

• Study topic:
  Disease /health condition

  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Effectiveness study (incl. comparative)

Study drug and medical condition

• Medicinal product name, other:
  Lacosamide
• Study drug International non-proprietary name (INN) or common name:
  LACOSAMIDE
• Anatomical Therapeutic Chemical (ATC) code:
  (N03AX18) lacosamide

  lacosamide
• Medical condition to be studied:
  Neonatal seizure

Population studied

• Age groups:
  • Neonate

    • Preterm newborn infants (0 – 27 days)
    • Term newborn infants (0 – 27 days)

Study design details

• Comparators:
  Other Antiseizure Medications for Neonatal Seizures.